BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9243392)

  • 21. Gadolinium-enhanced breast MRI.
    Kelcz F; Santyr G
    Crit Rev Diagn Imaging; 1995; 36(4):287-338. PubMed ID: 8845065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Half-Fourier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: initial characterization of breast lesions.
    Perman WH; Heiberg EV; Herrmann VM
    Radiology; 1996 Jul; 200(1):263-9. PubMed ID: 8657924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic MRI of the breast.
    Ercolani P; Valeri G; Amici F
    Eur J Radiol; 1998 May; 27 Suppl 2():S265-71. PubMed ID: 9652533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MR imaging for breast cancer].
    Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography.
    Hoffmann U; Brix G; Knopp MV; Hess T; Lorenz WJ
    Magn Reson Med; 1995 Apr; 33(4):506-14. PubMed ID: 7776881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.
    Boné B; Péntek Z; Perbeck L; Veress B
    Acta Radiol; 1997 Jul; 38(4 Pt 1):489-96. PubMed ID: 9240665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study.
    Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T
    Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced magnetic resonance imaging of the breast.
    Heywang-Köbrunner SH
    Invest Radiol; 1994 Jan; 29(1):94-104. PubMed ID: 8144345
    [No Abstract]   [Full Text] [Related]  

  • 33. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
    Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
    Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 35. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
    Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
    Siewert C; Oellinger H; Sherif HK; Blohmer JU; Hadijuana J; Felix R
    MAGMA; 1997 Mar; 5(1):29-31. PubMed ID: 9219176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging.
    Hickman PF; Moore NR; Shepstone BJ
    Br J Radiol; 1994 Jan; 67(793):14-20. PubMed ID: 8298869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images.
    Mussurakis S; Gibbs P; Horsman A
    Radiology; 1998 Feb; 206(2):465-73. PubMed ID: 9457201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic magnetic resonance imaging in evaluating suspicious breast lesions: correlation with pathologic findings.
    Snow RD; Dyess DL; Harpen MD; Kreisberg CN; Tucker JA
    South Med J; 1998 Jun; 91(6):527-32. PubMed ID: 9634113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma.
    Murray AD; Redpath TW; Needham G; Gilbert FJ; Brookes JA; Eremin O
    Br J Radiol; 1996 Jul; 69(823):594-600. PubMed ID: 8696694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.